303 related articles for article (PubMed ID: 29179815)
1. CHARGE syndrome modeling using patient-iPSCs reveals defective migration of neural crest cells harboring CHD7 mutations.
Okuno H; Renault Mihara F; Ohta S; Fukuda K; Kurosawa K; Akamatsu W; Sanosaka T; Kohyama J; Hayashi K; Nakajima K; Takahashi T; Wysocka J; Kosaki K; Okano H
Elife; 2017 Nov; 6():. PubMed ID: 29179815
[TBL] [Abstract][Full Text] [Related]
2. Sema3E is required for migration of cranial neural crest cells in zebrafish: Implications for the pathogenesis of CHARGE syndrome.
Liu ZZ; Guo J; Lu Y; Liu W; Fu X; Yao T; Zhou Y; Xu HA
Int J Exp Pathol; 2019 Aug; 100(4):234-243. PubMed ID: 31464029
[TBL] [Abstract][Full Text] [Related]
3. CHD7 cooperates with PBAF to control multipotent neural crest formation.
Bajpai R; Chen DA; Rada-Iglesias A; Zhang J; Xiong Y; Helms J; Chang CP; Zhao Y; Swigut T; Wysocka J
Nature; 2010 Feb; 463(7283):958-62. PubMed ID: 20130577
[TBL] [Abstract][Full Text] [Related]
4. CHD7, the gene mutated in CHARGE syndrome, regulates genes involved in neural crest cell guidance.
Schulz Y; Wehner P; Opitz L; Salinas-Riester G; Bongers EM; van Ravenswaaij-Arts CM; Wincent J; Schoumans J; Kohlhase J; Borchers A; Pauli S
Hum Genet; 2014 Aug; 133(8):997-1009. PubMed ID: 24728844
[TBL] [Abstract][Full Text] [Related]
5. CHARGEd with neural crest defects.
Pauli S; Bajpai R; Borchers A
Am J Med Genet C Semin Med Genet; 2017 Dec; 175(4):478-486. PubMed ID: 29082625
[TBL] [Abstract][Full Text] [Related]
6. Chromatin remodeler CHD7 targets active enhancer region to regulate cell type-specific gene expression in human neural crest cells.
Sanosaka T; Okuno H; Mizota N; Andoh-Noda T; Sato M; Tomooka R; Banno S; Kohyama J; Okano H
Sci Rep; 2022 Dec; 12(1):22648. PubMed ID: 36587182
[TBL] [Abstract][Full Text] [Related]
7. Sema3a plays a role in the pathogenesis of CHARGE syndrome.
Ufartes R; Schwenty-Lara J; Freese L; Neuhofer C; Möller J; Wehner P; van Ravenswaaij-Arts CMA; Wong MTY; Schanze I; Tzschach A; Bartsch O; Borchers A; Pauli S
Hum Mol Genet; 2018 Apr; 27(8):1343-1352. PubMed ID: 29432577
[TBL] [Abstract][Full Text] [Related]
8. Rescue of neural crest-derived phenotypes in a zebrafish CHARGE model by Sox10 downregulation.
Asad Z; Pandey A; Babu A; Sun Y; Shevade K; Kapoor S; Ullah I; Ranjan S; Scaria V; Bajpai R; Sachidanandan C
Hum Mol Genet; 2016 Aug; 25(16):3539-3554. PubMed ID: 27418670
[TBL] [Abstract][Full Text] [Related]
9. Etiology and functional validation of gastrointestinal motility dysfunction in a zebrafish model of CHARGE syndrome.
Cloney K; Steele SL; Stoyek MR; Croll RP; Smith FM; Prykhozhij SV; Brown MM; Midgen C; Blake K; Berman JN
FEBS J; 2018 Jun; 285(11):2125-2140. PubMed ID: 29660852
[TBL] [Abstract][Full Text] [Related]
10. Correction of Hirschsprung-Associated Mutations in Human Induced Pluripotent Stem Cells Via Clustered Regularly Interspaced Short Palindromic Repeats/Cas9, Restores Neural Crest Cell Function.
Lai FP; Lau ST; Wong JK; Gui H; Wang RX; Zhou T; Lai WH; Tse HF; Tam PK; Garcia-Barcelo MM; Ngan ES
Gastroenterology; 2017 Jul; 153(1):139-153.e8. PubMed ID: 28342760
[TBL] [Abstract][Full Text] [Related]
11. Chromatin remodeler CHD7 regulates the stem cell identity of human neural progenitors.
Chai M; Sanosaka T; Okuno H; Zhou Z; Koya I; Banno S; Andoh-Noda T; Tabata Y; Shimamura R; Hayashi T; Ebisawa M; Sasagawa Y; Nikaido I; Okano H; Kohyama J
Genes Dev; 2018 Jan; 32(2):165-180. PubMed ID: 29440260
[TBL] [Abstract][Full Text] [Related]
12. Role of rare cases in deciphering the mechanisms of congenital anomalies: CHARGE syndrome research.
Kosaki K
Congenit Anom (Kyoto); 2011 Mar; 51(1):12-5. PubMed ID: 21338411
[TBL] [Abstract][Full Text] [Related]
13. EIF4A3 deficient human iPSCs and mouse models demonstrate neural crest defects that underlie Richieri-Costa-Pereira syndrome.
Miller EE; Kobayashi GS; Musso CM; Allen M; Ishiy FAA; de Caires LC; Goulart E; Griesi-Oliveira K; Zechi-Ceide RM; Richieri-Costa A; Bertola DR; Passos-Bueno MR; Silver DL
Hum Mol Genet; 2017 Jun; 26(12):2177-2191. PubMed ID: 28334780
[TBL] [Abstract][Full Text] [Related]
14. CHD7 regulates cardiovascular development through ATP-dependent and -independent activities.
Yan S; Thienthanasit R; Chen D; Engelen E; Brühl J; Crossman DK; Kesterson R; Wang Q; Bouazoune K; Jiao K
Proc Natl Acad Sci U S A; 2020 Nov; 117(46):28847-28858. PubMed ID: 33127760
[No Abstract] [Full Text] [Related]
15. Immunological Properties of Neural Crest Cells Derived from Human Induced Pluripotent Stem Cells.
Fujii S; Yoshida S; Inagaki E; Hatou S; Tsubota K; Takahashi M; Shimmura S; Sugita S
Stem Cells Dev; 2019 Jan; 28(1):28-43. PubMed ID: 30251915
[TBL] [Abstract][Full Text] [Related]
16. Generation of a human iPSC line (FDCHi009-A) from a patient with CHARGE syndrome carrying a novel CHD7 mutation (c.2939 T > C).
Peng T; Cheng Y; Xiong M; Cheng G
Stem Cell Res; 2023 Feb; 66():102996. PubMed ID: 36502621
[TBL] [Abstract][Full Text] [Related]
17. Human Pluripotent Stem Cell-Derived Neural Crest Cells for Tissue Regeneration and Disease Modeling.
Srinivasan A; Toh YC
Front Mol Neurosci; 2019; 12():39. PubMed ID: 30853889
[TBL] [Abstract][Full Text] [Related]
18. Establishment of an induced pluripotent stem cell line from a patient with CHARGE syndrome carrying a CHD7 (p.L1151Gfs*17) mutation.
He S; Hu J; Zheng Z; Wang J; Chen J; Zhang C; Li L; Wang J; Chen Z; Shi H; Wang J
Stem Cell Res; 2020 May; 45():101774. PubMed ID: 32247258
[TBL] [Abstract][Full Text] [Related]
19. Neural crest stem cells and their potential therapeutic applications.
Liu JA; Cheung M
Dev Biol; 2016 Nov; 419(2):199-216. PubMed ID: 27640086
[TBL] [Abstract][Full Text] [Related]
20. LNGFR
Ouchi T; Morikawa S; Shibata S; Fukuda K; Okuno H; Fujimura T; Kuroda T; Ohyama M; Akamatsu W; Nakagawa T; Okano H
Differentiation; 2016 Dec; 92(5):270-280. PubMed ID: 27178356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
